Holen Sie sich die Stockscreener-App
63.12
0.46%
-0.3209
Schlusskurs vom Vortag:
$63.44
Offen:
$63.3
24-Stunden-Volumen:
3,660
Relative Volume:
0.12
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-3.85%
1M Leistung:
+8.55%
6M Leistung:
+36.67%
1J Leistung:
+69.35%
1-Tages-Spanne:
$62.73
$63.50
1-Wochen-Bereich:
$62.73
$65.54
52-Wochen-Spanne:
$36.00
$68.00
Global X Genomics Biotechnology Etf Stock (GNOM) Company Profile
Firmenname
Global X Genomics Biotechnology Etf
Sektor
Branche
Telefon
-
Adresse
-
Compare GNOM vs VTI, SPY, IVV, VB, QQQ
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GNOM
Global X Genomics Biotechnology Etf
|
63.50 | 0 | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
376.50 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
763.86 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
767.50 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
295.95 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
718.11 | 124.43B | 0 | 0 | 0 | 0.00 |
Global X Genomics Biotechnology Etf Aktie (GNOM) Neueste Nachrichten
Global X Genomics & Biotechnology ETF (NASDAQ: GNOM) Stock Price, News & Analysis - Kalkine
(GNOM) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Through the Systematic Lens: Thematic Equity: Factor Landscape (August 2026) - Global X ETFs
How to Buy Moderna Stock (MRNA) in 2026 - The Motley Fool
Healthcare ETFs rally as Moderna nearly doubles on melanoma win - Seeking Alpha
Global X Genomics & Biotechnology UCITS ETFUSDChart Real-time | ETF | GNOG | IE00BM8R0N95 - marketscreener.com
5 Best CRISPR Gene Editing ETFs for 2026 and How to Invest - The Motley Fool
Global X Genomics & Biotechnology ETF (GNOM) Stock Price, News, Quote & History - Yahoo! Finance Canada
Precision Trading with Global X Genomics & Biotechnology Etf (GNOM) Risk Zones - Stock Traders Daily
GNOM Dividend: 1.12% Yield, $0.65/Share — History & Dates - GuruFocus
GNOMZ ETF Profile: Dividends, Returns (AQUISUK:GNOMZ) - TradingView
Global X Genomics & Biotechnology ETF Shs Unsponsored Brazilian Depositary Receipt Repr 0.16666667 Sh - TradingView
Technical Reactions to GNOM Trends in Macro Strategies - Stock Traders Daily
Uniqure NV (QURE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Veracyte Inc (VCYT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Pacific Biosciences of California Inc (PACB) Shareholder Structure: Major Shareholders & Institutional Holdings - tradingkey.com
CRISPR Therapeutics AG (CRSP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Caribou Biosciences Inc (CRBU) Shareholder Structure: Major Shareholders & Institutional Holdings - tradingkey.com
Sarepta Therapeutics Inc (SRPT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Natera Inc (NTRA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Rocket Pharmaceuticals Inc (RCKT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Qiagen NV (QGEN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Myriad Genetics Inc (MYGN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Alnylam Pharmaceuticals Inc (ALNY) Shareholder Structure: Major Shareholders & Institutional Holdings - tradingkey.com
Intellia Therapeutics Inc (NTLA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Arrowhead Pharmaceuticals Inc (ARWR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Beam Therapeutics Inc (BEAM) Shareholder Structure: Major Shareholders & Institutional Holdings - tradingkey.com
Ultragenyx Pharmaceutical Inc (RARE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Allogene Therapeutics Inc (ALLO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Regenxbio Inc (RGNX) Shareholder Structure: Major Shareholders & Institutional Holdings - tradingkey.com
WAVE Life Sciences Ltd (WVE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Scilex Holding Co (SCLX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Prime Medicine Inc (PRME) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Maravai LifeSciences Holdings Inc (MRVI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bio-Techne Corp (TECH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Arcturus Therapeutics Holdings Inc (ARCT) Shareholder Structure: Major Shareholders & Institutional Holdings - tradingkey.com
Biontech SE (BNTX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Legend Biotech Corp (LEGN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Guardant Health Inc (GH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Illumina Inc (ILMN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Personalis Inc (PSNL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Sana Biotechnology Inc (SANA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Avidity Biosciences Inc (RNA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Twist Bioscience Corp (TWST) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Vir Biotechnology Inc (VIR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Agilent Technologies Inc (A) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Moderna Inc (MRNA) Shareholder Structure: Major Shareholders & Institutional Holdings - tradingkey.com
GNOM Archives - 24/7 Wall St.
ARKG and GNOM ETFs offer different genomic bets with varied risk and returns in 2026. - Pluang
ETF Showdown: ARKG vs GNOM, Which Genomics Fund Wins? - 24/7 Wall St.
ETFs Investing in Rocket Pharmaceuticals, Inc. Stocks - TradingView
Finanzdaten der Global X Genomics Biotechnology Etf-Aktie (GNOM)
Es liegen keine Finanzdaten für Global X Genomics Biotechnology Etf (GNOM) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.52%
2.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):